Press release
Human Insulin Market Size, Share, Trends, Growth and Forecast 2023-2028
Human insulin (HI), or regular insulin, is a short-acting form of insulin naturally occurring in the human body and is typically administered through subcutaneous injections several times a day. It is employed to treat hyperglycemia caused due to type 1 and type 2 diabetes. It is manufactured by recombinant deoxyribonucleic acid (DNA) technology and is identical to endogenously made insulin. It is bio-engineered by growing insulin proteins cultivated within E-coli bacteria (Escherichia coli) cells. Additionally, it facilitates the uptake of glucose from the bloodstream into internal organs and tissues, including the liver and fat cells, to use as energy. It also inhibits the production of glucose in the liver and promotes protein synthesis within the body to use as energy. Currently, manufacturers are introducing an inhalable variant specifically developed to serve as a meal-time bolus insulin. As a result, human insulin (HI) is easily available in retail and hospital pharmacies and online retail stores across the globe.
Request Your Sample Report Now: https://www.imarcgroup.com/human-insulin-market/requestsample
Human Insulin Market Trends and Drivers:
The market is primarily driven by the increasing occurrences of diabetes due to sedentary lifestyles, geriatric population, and unhealthy dietary habits. Additionally, the growing awareness among consumers about the complications associated with long-term diabetes, such as heart attacks, cataracts, and kidney failure, is contributing to the market growth. In line with this, the rising demand for biosimilar drugs due to their effectiveness and cost-efficiency is influencing market growth. Moreover, the introduction of pen devices and safety pen needles, which minimize discomfort and reduce the risks of infections, injuries, and transmission of bloodborne pathogens, represents another major growth-inducing factor. Besides this, the implementation of stringent government regulations to prevent needle stick injuries and the shift in consumer preferences toward minimally invasive (MI) devices have promoted the use of pen devices and safety pen needles for delivering human insulin, thus accelerating the product adoption rate. Along with this, recent advancements in biotechnology, ongoing product innovations, and the development of novel insulin products are propelling market growth. For instance, in May 2022, Eli Lilly and Company obtained approval for the Mounjaro injection, a treatment that facilitates the improvement of glycemic control in individuals diagnosed with type 2 diabetes. Apart from this, human insulin (HI) is growing at different rates in numerous regions, with North America being one of the largest markets due to a sedentary lifestyle, rising occurrences of diabetes, and several technological advancements. Moreover, the industry is expected to face competition in the upcoming years as various key players are implementing competitive strategies to sustain their presence in the market. For instance, in June 2020, the U.S. Food and Drug Administration granted approval to Lyumjev, a rapid-acting insulin developed by Eli Lilly and Company to enhance glycemic control in adults diagnosed with type 1 and type 2 diabetes. Furthermore, improving healthcare infrastructure, increasing consumer health consciousness, and extensive investment in research and development (R&D) activities to develop oral insulin variants that offer an effective, safe, and convenient are creating a positive market outlook.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
B. Braun Melsungen AG
Becton
Dickinson and Company (BD)
Biocon
Eli Lilly and Company
Gulf Pharmaceutical Industries (Julphar)
Novo Nordisk A/S
Pfizer Inc.
Groupe Sanofi
SEDICO Co.
Wockhardt Limited
Ypsomed AG
Explore full report with table of contents: https://www.imarcgroup.com/human-insulin-market
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Product Type:
Drugs
Human Insulin Analogs and Biosimilars
Rapid Acting
Long Acting
Premixed
Human Insulin Biologics
Short Acting
Intermediate Acting
Premixed
Delivery Devices
Pens
Reusable Pens
Disposable Pens
Pen Needles
Standard Pen Needles
Safety Pen Needles
Syringes
Others
Breakup by Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
Online Retail Stores
Others
Breakup by Disease Type:
Type I Diabetes
Type II Diabetes
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Insulin Market Size, Share, Trends, Growth and Forecast 2023-2028 here
News-ID: 3213219 • Views: …
More Releases from IMARC Group
Brewery Consulting Business Setup Guide: Revenue Model, Cost Analysis & Market I …
Overview:
IMARC Group's "Brewery Consulting Business Plan and Project Report 2025" provides a detailed and data-driven roadmap for establishing and operating a successful brewery consulting business. The report highlights industry performance, key market trends, operational models, investment needs, and profitability forecasts. It serves as a valuable resource for entrepreneurs, investors, consultants, and business strategists. It also offers comprehensive guidance on Brewery Consulting Business setup, covering infrastructure planning, service offerings, resource allocation,…
Xenon Prices, Latest Trend, Demand, Index & Uses 2025
North America Xenon Prices Movement Q2:
Xenon Prices in USA:
During the second quarter of 2025, Xenon Prices in the USA reached 2,966 USD/MT in June. Prices remained elevated due to restricted output from air separation units and steady demand from the semiconductor and medical imaging industries. Heavy reliance on imports added cost pressures, with logistics and procurement challenges further influencing final market prices. The supply environment stayed tight, with minimal fresh…
Philippines Potato Chips Market Size Worth USD 233.12 Million From 2025 to 2033
Market Overview
The Philippines potato chips market reached a market size of USD 158.40 Million in 2024. It is expected to grow to USD 233.12 Million by 2033, driven by factors such as rising premium snack demand, international brand presence, and expanding retail and e-commerce networks. These trends are improving product innovation and accessibility, broadening consumer options and frequency of purchase. The forecast period for this market is 2025-2033, with a…
Philippines Banking Market 2026 | Projected to Reach USD 62.6 Billion by 2034 | …
Market Overview
The Philippines banking market reached a size of USD 10.4 Billion in 2025 and is projected to expand to USD 62.6 Billion by 2034, exhibiting a growth of 22.07% CAGR. This growth is supported by rising financial inclusion, a growing middle class, and strong remittance inflows that boost household finances. Innovations in digital banking and fintech, supported by government policies promoting financial inclusion and cashless transactions, are transforming the…
More Releases for Human
Mooka: Replacing Human Error with AI - Not Human Connection
Salt Lake City, UT - October 21, 2025 - In an era where automation and artificial intelligence are reshaping nearly every corner of online retail, Mooka [https://www.mooka.io/], a leader in eCommerce automation and marketplace optimization, is taking a clear stand: AI should replace human error, not human interaction.
As eCommerce continues to scale, many sellers face a growing challenge-how to keep operations efficient while preserving the human touch that builds trust,…
Tennessee United for Human Rights Challenging Hate this Human Rights Day
Nashville, Tennessee, 10th October 2025, ZEX PR WIRE, Tennessee United for Human Rights (TNUHR) coordinates with human rights agencies across the state to organize the annual Human Rights Day celebration, set for December 10, 2025, in Nashville, Tennessee.
This year's theme, "Challenging Hate: Standing Together for Universal Human Rights," reflects the ongoing commitment of local organizations to unite communities, confront prejudice, and promote equality and understanding for all.
The celebration will honor…
Global Human Augmentation Market 2024-2031: Advancing Human Potential Through Te …
Global Human Augmentation Market reached US$ 252.6 Billion in 2023 and is expected to reach US$ 780.7 Billion by 2031, growing with a CAGR of 15.6% during the forecast period 2024-2031.
The Human Augmentation Market focuses on technologies enhancing human capabilities through wearable exoskeletons, neural interfaces, prosthetics, and performance-enhancing devices. Growth is fueled by medical rehabilitation, industrial automation, defense applications, and lifestyle technology. Advances in robotics, AI, and brain-computer interfaces expand…
Human Factors and Usability Engineering Services Market Key Players Analysis - H …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Human Factors and Usability Engineering Services Market"-, By Steps Involved (Summative Study, Contextual Analysis, Formative Study, Known Use Error Analysis, Use Risk Analysis, Submission Preparation, Design Process and Task Analysis), By Type of Research Method (Evaluation Research and Generative Research), Class of Medical Device Tested (Class I, Class II and Class III ), Industry Trends, and…
Defending Human Life
Albert Covarrubias, Jr was fighting for his Constitutional rights and was killed in the line of duty by his own police force. There is no divine right to kill him for simply standing up for his rights. Every person has the right to stand for what they believe, rather than be gunned down. You cannot take away human life as being ok with simply saying it was a mistake.
If someone…
I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern…
